Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Collaborate
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
About
About
EQOH
Careers
Contact Us
EMJ Gold
search
Join
FREE
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Collaborate
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
About
About
EQOH
Careers
Contact Us
EMJ Gold
Join
FREE
World Health Day 2023: Health for All
Today is World Health Day, and to celebrate GOLD asked Claire Gillis, CEO, VMLY&R Health, to share her thoughts on using creativity to create better access to healthcare for all
Innovation, collaboration and creativity as a contact sport
Magnus Björsne, CEO, AstraZeneca BioVentureHub, discusses the impact of the pandemic on innovation, collaboration and creativity.
Behind the hype of ChatGPT
Now that the world has had time to see the risks and rewards of ChatGPT, pharma industry must decide whether to take it or leave it. Read for more.
Pharma in China, untapped markets and drug development
In this episode, Marc and Helena talk China with Novartis’ Isabel Afonso and drug development with Farid Khan, CEO of PharmaKure. Listen now!
Claire Skentelbery, Director General, EuropaBio
Bonus episode this week for GOLD podcast, featuring a full feature-length interview with Claire Skentelbery, Director General, EuropaBio. Stream now!
FDA approves first-in-class cancer checkpoint inhibitor
A new type of checkpoint inhibitor to treat unresectable or metastatic melanoma has been approved by the FDA.
Industry welcomes UK-wide commitment to genomic research
Better genomic testing and access to clinical trials have been prioritised and agreed by the UK government and devolved administrations. Read for more details.
The risks, rewards and future potential of biotechnology
In this episode, Marc and Helena have a chat about biotech with special guest Claire Skentelbery, Director General of EuropaBio.
GP insights, preventative care and patient centricity
In this episode, Marc and Helena will chat with GP Nigel Guest about his thoughts about preventative medicines and his insights for pharma sales teams.
International Women’s Day special
In this special bumper episode, GOLD celebrates International Women’s Day by speaking to Nikki Jones (HBA) and Aliya Omer (Kite Pharma) about the role of women in pharma industry.
←
1
2
3
…
12
13
14
15
16
17
18
19
20
→
We’ve noticed you’re accessing
from
North/South America.
View
View